Healthcare provider profile · identity verified

Poonam Gogia, MD

Internal Medicine · HARLINGEN, TX · NPI 1891708913

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	978	318
Rosuvastatin Calcium	Rosuvastatin Calcium	905	314
Losartan Potassium	Losartan Potassium	707	232
Lisinopril	Lisinopril	696	230
Metformin Hcl	Metformin Hcl	610	207
Levothyroxine Sodium	Levothyroxine Sodium	559	177
Amlodipine Besylate	Amlodipine Besylate	443	158
Metoprolol Succinate	Metoprolol Succinate	357	129
Simvastatin	Simvastatin	299	92
Jardiance	Empagliflozin	257	93
Pantoprazole Sodium	Pantoprazole Sodium	242	104
Alendronate Sodium	Alendronate Sodium	207	84
Omeprazole	Omeprazole	173	77
Gabapentin	Gabapentin	169	88
Tamsulosin Hcl	Tamsulosin Hcl	158	68
Glipizide	Glipizide	156	56
Sertraline Hcl	Sertraline Hcl	146	54
Hydrochlorothiazide	Hydrochlorothiazide	142	52
Montelukast Sodium	Montelukast Sodium	136	54
Duloxetine Hcl	Duloxetine Hcl	133	65
Albuterol Sulfate Hfa	Albuterol Sulfate	121	56
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	108	91
Ozempic	Semaglutide	108	38
Trazodone Hcl	Trazodone Hcl	106	40
Carvedilol	Carvedilol	101	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	99	30
Fluticasone Propionate	Fluticasone Propionate	98	56
Metoprolol Tartrate	Metoprolol Tartrate	94	36
Eliquis	Apixaban	91	26
Clopidogrel	Clopidogrel Bisulfate	84	35
Famotidine	Famotidine	83	34
Escitalopram Oxalate	Escitalopram Oxalate	81	42
Furosemide	Furosemide	81	39
Glipizide Er	Glipizide	80	33
Januvia	Sitagliptin Phosphate	80	31
Donepezil Hcl	Donepezil Hcl	72	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	23
Sps	Sodium Polystyrene Sulfon/Sorb	60	47
Ciclopirox	Ciclopirox	56	26
Celecoxib	Celecoxib	55	37
Metformin Hcl Er	Metformin Hcl	55	21
Pravastatin Sodium	Pravastatin Sodium	54	20
Baclofen	Baclofen	53	50
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	53	17
Allopurinol	Allopurinol	50	13
Citalopram Hbr	Citalopram Hydrobromide	49	17
Spironolactone	Spironolactone	47	21
Glimepiride	Glimepiride	45	17
Solifenacin Succinate	Solifenacin Succinate	44	20
Finasteride	Finasteride	43	17
Memantine Hcl	Memantine Hcl	43	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	20
Olmesartan Medoxomil	Olmesartan Medoxomil	42	13
Hydralazine Hcl	Hydralazine Hcl	39	17
Trulicity	Dulaglutide	33	suppressed
Nystatin	Nystatin	32	25
Buspirone Hcl	Buspirone Hcl	31	17
Lantus	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	11
Sucralfate	Sucralfate	31	15
Valsartan	Valsartan	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	22
Ondansetron Hcl	Ondansetron Hcl	30	25
Enalapril Maleate	Enalapril Maleate	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Ezetimibe	Ezetimibe	28	12
Oxybutynin Chloride Er	Oxybutynin Chloride	28	11
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	23
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	16
Farxiga	Dapagliflozin Propanediol	23	11
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Rybelsus	Semaglutide	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Fluconazole	Fluconazole	20	18
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Ramipril	Ramipril	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Cephalexin	Cephalexin	18	17
Linzess	Linaclotide	18	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Nitroglycerin	Nitroglycerin	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Azithromycin	Azithromycin	16	16
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	15	15
Easy Comfort Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Estradiol	Estradiol	15	14
Jantoven	Warfarin Sodium	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Pro Comfort Pen Needle	Pen Needle, Diabetic	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	12
Propranolol Hcl	Propranolol Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Colchicine	Colchicine	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Folic Acid	Folic Acid	11	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	11	suppressed
Prolia	Denosumab	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error